U.S. Wealth WatcherCelebrating Political Fortunes
‹ Lobbying

Hereditary Hemorrhagic Telangiectasia Foundation

MD · 4 filings, 2025

Lobbying spend · 2025
$40K
to shape legislation
About the organization

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease and Osler–Weber–Rendu syndrome, is a rare autosomal dominant genetic disorder that leads to abnormal blood vessel formation in the skin, mucous membranes, and often in organs such as the lungs, liver, and brain. It may lead to nosebleeds, acute and chronic digestive tract bleeding, and various problems due to the involvement of other organs. via Wikipedia ↗

1Lobbies on

Its filings list: Defense · Health Issues

2Through these firms · 1

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

3Bills moving in its lanes

No bill names this company outright; these are recent bills in the sectors it lobbies.